333

UNITED LABORATORIES INTL HLDGS LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪19.48 B‬HKD
‪2.98 B‬HKD
‪15.18 B‬HKD
‪966.13 M‬
Beta (1Y)
0.68
Employees (FY)
‪15 K‬
Change (1Y)
‪+1 K‬ +7.14%
Revenue / Employee (1Y)
‪129.59 K‬HKD
Net income / Employee (1Y)
‪25.48 K‬HKD

About UNITED LABORATORIES INTL HLDGS LTD


Headquarters
Hong Kong
Founded
1990
Website
FIGI
BBG000JZ6DW1
The United Laboratories International Holdings Ltd. is an investment company, which engages in manufacturing and selling medicine products. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment represents sales of 6-APA products and penicillin G potassium products. The Bulk Medicine segment covers the sales of amoxicillin products. The Finished Products segment sells insulin series products, antibiotics products, nervous system drugs, ophthalmic products, and veterinary drugs. The company was founded in 1990 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 3933 is 10.82 HKD — it has increased by 0.75% in the past 24 hours. Watch UNITED LABORATORIES INTL HLDGS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange UNITED LABORATORIES INTL HLDGS LTD stocks are traded under the ticker 3933.
3933 stock has fallen by −2.88% compared to the previous week, the month change is a 4.85% rise, over the last year UNITED LABORATORIES INTL HLDGS LTD has showed a 34.58% increase.
We've gathered analysts' opinions on UNITED LABORATORIES INTL HLDGS LTD future price: according to them, 3933 price has a max estimate of 15.05 HKD and a min estimate of 9.26 HKD. Watch 3933 chart and read a more detailed UNITED LABORATORIES INTL HLDGS LTD stock forecast: see what analysts think of UNITED LABORATORIES INTL HLDGS LTD and suggest that you do with its stocks.
3933 reached its all-time high on Sep 14, 2010 with the price of 15.88 HKD, and its all-time low was 1.54 HKD and was reached on Nov 7, 2008. View more price dynamics on 3933 chart.
See other stocks reaching their highest and lowest prices.
3933 stock is 2.98% volatile and has beta coefficient of 0.68. Track UNITED LABORATORIES INTL HLDGS LTD stock price on the chart and check out the list of the most volatile stocks — is UNITED LABORATORIES INTL HLDGS LTD there?
Today UNITED LABORATORIES INTL HLDGS LTD has the market capitalization of ‪19.48 B‬, it has decreased by −2.02% over the last week.
Yes, you can track UNITED LABORATORIES INTL HLDGS LTD financials in yearly and quarterly reports right on TradingView.
UNITED LABORATORIES INTL HLDGS LTD is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
3933 earnings for the last half-year are 0.88 HKD per share, whereas the estimation was 0.82 HKD, resulting in a 8.00% surprise. The estimated earnings for the next half-year are 0.85 HKD per share. See more details about UNITED LABORATORIES INTL HLDGS LTD earnings.
UNITED LABORATORIES INTL HLDGS LTD revenue for the last half-year amounts to ‪7.71 B‬ HKD, despite the estimated figure of ‪7.82 B‬ HKD. In the next half-year revenue is expected to reach ‪7.99 B‬ HKD.
3933 net income for the last half-year is ‪1.62 B‬ HKD, while the previous report showed ‪1.53 B‬ HKD of net income which accounts for 5.58% change. Track more UNITED LABORATORIES INTL HLDGS LTD financial stats to get the full picture.
UNITED LABORATORIES INTL HLDGS LTD dividend yield was 8.13% in 2023, and payout ratio reached 34.68%. The year before the numbers were 5.62% and 27.28% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 5, 2024, the company has ‪15.00 K‬ employees. See our rating of the largest employees — is UNITED LABORATORIES INTL HLDGS LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UNITED LABORATORIES INTL HLDGS LTD EBITDA is ‪4.38 B‬ HKD, and current EBITDA margin is 27.38%. See more stats in UNITED LABORATORIES INTL HLDGS LTD financial statements.
Like other stocks, 3933 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNITED LABORATORIES INTL HLDGS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So UNITED LABORATORIES INTL HLDGS LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating UNITED LABORATORIES INTL HLDGS LTD stock shows the strong buy signal. See more of UNITED LABORATORIES INTL HLDGS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.